CHAPTER 1909: CHAPTER 1734: HEADS HELD HIGH ON ARRIVAL, HEADS HUNG LOW ON DEPARTURE

The news broke.

The excitement was overwhelming.

"What a big deal!"

"Looks like they’re aiming for provincial coverage. Makes sense, after half a year of clinical trials, zero medical accidents, 100% cure rate, they sure want to promote it. Buying this is better than buying Maotai."

"I’m dying of laughter!"

"Maotai? Such an old joke."

"Exactly."

"They said they imported a large number of operating rooms; at this rate, won’t surgical doctors be out of jobs? Decades of clinical surgery experience, if wasted like this, it’s truly a pity."

"The pain of technological progress."

"A prevailing trend."

"Allowing you to live is justice."

"Yeah, yeah."

"I only have one life."

"Hope it comes soon. I booked an appointment for Father in Myanmar, and it’s queued until next June. Booking in Beijing, and it’s queued until next August. Just hoping for it to come sooner, so we don’t have to leave the province."

"Same here, running to the province is troublesome, going to Beijing and Myanmar is even worse. Food, lodging, transportation, ten thousand bucks is not enough. Hope one day it can spread to city level, that would be the best."

"Dreaming."

"Do you know how expensive the equipment is?"

"One billion for a diagnostic cabin, the most expensive operating room is ten billion. At most, it can be popularized in populous prefecture-level cities and provincial level cities, don’t even dream about other places."

"No wonder they spent hundreds of billions."

"Good buy."

"..."

The Huaxia netizens are overwhelmingly supportive. Booking in Myanmar is too slow, and too far, accommodation is a problem, and Beijing trial spots are just a few hospitals, it’s hard to meet nationwide demand.

This time.

One set per province, without even needing to go to Beijing.

How nice.

...

The United States.

Online.

A plethora of doubts.

"We need transcription fluid, diagnostic cabins, operating rooms, drugs that can treat senile dementia. Is it so hard to get these life-saving drugs approved?"

"Exactly."

"Huaxia and India have both caught up."

"What are we waiting for?"

"Waiting for Germany’s alternative products? Even if they have the same efficacy, they don’t have the mature transcription fluid technology. An experimental-level technology, who knows how long before it’s available for treatment."

"Strongly suggest, special approval for direct market entry."

"We need operating rooms."

"..."

Even in the United States, most are average families, going to Myanmar is costly. Huaxia’s trial has been almost a year, India half a year, and treated hundreds of thousands of terminal patients.

Common diseases.

We can endure.

Slow a bit.

Seeing a doctor, waiting days before seeing one, scheduling a surgery, waiting months.

That’s fine.

We can tolerate all this.

However.

Cancer is fatal, since the treatment works, why is the U.S. not moving at all, Huaxia, India, Myanmar, plus many African countries aided by Myanmar’s Pharmaceutical Group.

These countries combined, the population exceeds half the global total.

Still waiting.

Waiting for what?

Waiting for others to bring money? Thinking about it, many are filled with anger, the U.S. medical system sustains numerous pharmaceutical companies through exploiting insurance, maintaining ultra-high treatments for doctors.

That was before.

Now.

Many refuse to endure it anymore, previously there was no choice, the U.S. was also at the forefront of the global medical field. But now, a single foreign tooth extraction treatment can treat cancer, who would still accommodate you.

But.

These voices mainly circulate online, while major Western media are collectively silent.

Soon.

The discussion shifted towards the Duha Research Institute.

It’s been months.

Alternative products.

Where are they?

Talk of research.

Every few days, it’s in the news, mentioning how much investment obtained, how many awards received, how many industry leaders visited, but when will it be mass-produced, when will prices come down.

No definite news at all.

...

Germany.

Duha Research Institute.

"Sigh!"

Seeing the news, Fred was incredibly envious, over a thousand billion, almost one hundred and fifty billion dollars, and that’s just for a year. If he could make that money, wouldn’t it be great, but it’s just wishful thinking.

Even if he obtained transcription fluid technology.

The consortium wouldn’t give it to him.

"Mr. Fred, there’s public opinion online questioning the institute."

"Questioning what?"

"Mass production time, and price."

"Oh."

Fred breathed a sigh of relief.

As long as it’s not questioning authenticity, it’s good. It’s all just a bluff anyway, but we can’t do absolutely nothing. "Announce to the public that we have already reduced to the same cost as transcription fluid."

It’s all a bluff anyway.

Not afraid of adding one more.

Soon.

The public opinion quickly turned to praise, and internet ghost army, they would hire them too.

...

Airport.

"Goodbye."

Sun Jiang bid farewell to the delegation.

"Let’s grab a drink sometime."

"Good."

This circle, although large, is actually quite small, everyone has known each other for years, though others are more powerful, higher ranked than himself, Sun Jiang is a Level 2 Envoy, equal to the second in command in prefecture-level cities.

Shortly.

Seeing them all go in, Sun Jiang was about to turn around, but paused, seeing a group of Indians come out, among them, some Indian envoys he’d met a few times before, immediately understanding they were also coming to negotiate purchases.

In this line of work.

Memory is essential.

It’s seen that last year’s two people who discussed transcription fluid matters appeared, they’d been in the news. Seeing Sun Jiang, the Indian envoy smiled and nodded at him, Sun Jiang politely responded.

...

Thought today would be uneventful.

Afternoon.

Three thirty.

"Pfft!"

Sun Jiang was shocked by a ’small path’ news, couldn’t hold it.

"Hahaha!"

Couldn’t help but laugh.

Turns out.

The Indian representative immediately proposed purchasing three million doses of transcription fluid, averaging usage could treat nearly eight hundred thousand patients, but the price requested was one-fifth of the original.

Didn’t hear it wrong.

India wants transcription fluid to be priced down to one-fifth of the original, reasoning that alternatives to transcription fluid have appeared, Fred said, it might be possible to lower to one-fifth of transcription fluid or even lower.

Now.

It’s only been two months.

It’s already equal to transcription fluid.

And.

They want a discount purchase.

No way.

The Pharmaceutical Group from Myanmar left right away, and Myanmar’s Health General Administration didn’t give any face, directly departed, leaving the delegation there. As for when the next negotiation starts, it’s undecided yet.

One-fifth.

Sun Jiang pursed his lips.

Crazy.

We only negotiated a discount, still at 85 percent, a slightly better deal than equipment, you want it as low as 20 percent, if they really do that, then they’d be fools; he suddenly had an interest in watching the show.

...

"Why so impulsive, that’s too disrespectful, business is negotiated, if two percent isn’t viable, it can be discussed, yet you left directly. That shows disrespect to us, I want to protest."

"Bang!"

The leader of the negotiation group slammed the table.

"They were too rude."

Regarding this.

The not far-off envoy’s mouth twitched.

Bro.

Were you here for negotiation or to mess things up, two percent? Did you think it was discussing the wholesale cost of a pair of shoes with the manufacturer? If he knew he’d be listening in, he’d regret coming.

Embarrassing.

"Why act so high and mighty, wait till the alternatives come down, see them begging us to buy."

"Exactly."

"Haven’t Huaxia negotiated with the basic price as the prior one?"

"Impossible."

"..."

They don’t know about Huaxia’s procurement contract, but in the presence of alternatives, Huaxia still made large-scale purchases, they naturally assumed there was a bargain to be had, that’s why they followed.

Could it be.

That’s not the case?

...

Two days later.

Came with heads held high.

Left with heads bowed.

Three days, a 95 percent price, and not a bit of bargain. Instead, it turned out to be quite an amusing show. The Indian delegation wished they could dig a hole to hide in, though it wasn’t reported outside, it had already become an international joke.